imatinib mesylate has been researched along with Chickenpox in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cortes, JE; Ferrajoli, A; Giles, FJ; Kantarjian, HM; Kontoyiannis, D; Mattiuzzi, GN; Raad, I; Reuben, J; Rios, MB; Shan, J; Talpaz, M; Verstovsek, S | 1 |
1 other study(ies) available for imatinib mesylate and Chickenpox
Article | Year |
---|---|
Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Chickenpox; Female; Herpes Zoster; Herpesvirus 3, Human; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines | 2003 |